Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1231-1234

  Wlaź, Piotr ^a   Poleszak, Ewa ^b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

D cycloserine; Glycine; L 701,324; Maximal electroshock; Mice; NMDA; Seizure threshold

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; CYCLOSERINE; GLYCINE; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SEIZURE; SEIZURE THRESHOLD;

EID: 83155172707     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70643-0     Document Type: Article

References (19)

1. Carter AJ: Glycine antagonists: regulation the NMDA receptor-channel by the strychnine-insensitive glycine site. Drugs Future, 1992, 17, 595-613.
2. Danysz W, Parsons CG: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev, 1998, 50, 597-664. (Pubitemid 29028813)
3. B receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Eur J Pharmacol, 1997, 322, 179-184.
4. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature, 1987, 325, 529-531. (Pubitemid 17056733)
5. Kalinichev M, Starr KR, Teague S, Bradford AM, Porter RA, Herdon HJ: Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test. Brain Res, 2010, 1331, 105-113.
6. Kimball AW, Burnett WT, Jr., Doherty DG: Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res, 1957, 7, 1-12.
7. Kulagowski JJ, Baker R, Curtis NR, Leeson PD, Mawer IM, Moseley AM, Ridgill MP et al.: 3′-(Arylmethyl)- and 3′-(aryloxy)-3-phenyl-4- hydroxyquinolin- 2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J Med Chem, 1994, 37, 1402-1405. (Pubitemid 24174074)
8. Lanthorn TH: D-cycloserine: agonist turned antagonist. Amino Acids, 1994, 6, 247-260.
9. Löscher W, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res, 1991, 8, 79-94.
10. Löscher W, Wlaź P, Rundfeldt C, Baran H, Hönack D: Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol, 1994, 112, 97-106.
11. Peterson SL: 7-Chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures. Epilepsy Res, 1992, 13, 73-81.
12. Peterson SL, Schwade ND: The anticonvulsant activity of D-cycloserine is specific for tonic convulsions. Epilepsy Res, 1993, 15, 141-148. (Pubitemid 23188495)
13. Poleszak E, Wlaź P, Wróbel A, Dybała M, Sowa M, Fidecka S, Pilc A, Nowak G: Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep, 2007, 59, 595-600.
14. Poleszak E, Wlaź P, Wróbel A, Fidecka S, Nowak G: NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep, 2008, 60, 655-663.
15. Socała K, Nieoczym D, Rundfeldt C, Wlaź P: Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models. Pharmacol Rep, 2010, 62, 392-397.
16. Von Lubitz DK, Lin RC, McKenzie RJ, Devlin TM, McCabe RT, Skolnick P: A novel treatment of global cerebral ischaemia with a glycine partial agonist. Eur J Pharmacol, 1992, 219, 153-158.
17. B receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res Bull, 1998, 46, 535-540.
18. Wlaź P, Baran H, Löscher W: Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Eur J Pharmacol, 1994, 257, 217-225.
19. B receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats. Neuropharmacology, 1999, 38, 243-251.